Sanofi (EPA:SAN)
France flag France · Delayed Price · Currency is EUR
76.27
-0.89 (-1.15%)
Sep 3, 2026, 5:39 PM CET

Sanofi Cash Flow Statement

Millions EUR. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
3,9587,8135,5605,4008,3716,223
Depreciation & Amortization
3,4623,2573,1113,2473,0533,001
Other Amortization
17011210511997119
Loss (Gain) From Sale of Assets
178-79-298-103-470-357
Asset Writedown & Restructuring Costs
3,1472,3093691,062-42231
Loss (Gain) on Equity Investments
39929082293-45-15
Stock-Based Compensation
326313278260234244
Other Operating Activities
-1,674-5,287-43-1,456-879-389
Change in Accounts Receivable
-444-1,202-28-472-500185
Change in Inventory
-362-39-477-866-918-357
Change in Accounts Payable
-129398789258340451
Change in Other Net Operating Assets
2,7532,638-8991,4932841,130
Operating Cash Flow
11,83810,7509,08110,25810,52610,522
Operating Cash Flow Growth
5.56%18.38%-11.47%-2.55%0.04%41.84%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-1,799-1,762-1,733-1,619-1,529-1,478
Sale of Property, Plant & Equipment
8378471,4618071,340676
Cash Acquisitions
-10,186-9,394-1,901-2,535-987-5,594
Sale (Purchase) of Intangibles
-1,615-1,776-1,462-1,287-574-565
Investment in Securities
-450-684-623-92-353-269
Other Investing Activities
-60410,322-149-1,47428-68
Investing Cash Flow
-13,817-2,447-4,407-6,200-2,075-7,298

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
--59751216-
Long-Term Debt Issued
-5,559-481,549-
Total Debt Issued
3,5035,559597991,765-
Short-Term Debt Repaid
--1,100----414
Long-Term Debt Repaid
--2,955-953-3,936-2,998-2,390
Total Debt Repaid
-3,724-4,055-953-3,936-2,998-2,804
Net Debt Issued (Repaid)
-2211,504-894-3,137-1,233-2,804
Issuance of Common Stock
166177187195188186
Repurchase of Common Stock
-2,036-5,030-302-593-497-382
Common Dividends Paid
-4,923-4,772-4,704-4,454-4,168-4,008
Other Financing Activities
-36-86-50-63-111-48
Financing Cash Flow
-7,050-8,207-5,763-8,052-5,821-7,056

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
14-47-13-32815
Miscellaneous Cash Flow Adjustments
-167-167---
Net Cash Flow
-9,015216-1,269-4,0262,638-3,817

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
10,0398,9887,3488,6398,9979,044
Free Cash Flow Growth
5.47%22.32%-14.94%-3.98%-0.52%46.72%
Free Cash Flow Margin
20.52%19.24%16.59%21.02%22.32%23.09%
Free Cash Flow Per Share
8.287.335.856.887.167.19
Levered Free Cash Flow
6,29916,643-4,9447,1728,5147,336
Unlevered Free Cash Flow
6,67816,975-4,5437,5408,7657,562

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
539485587559380334
Cash Income Tax Paid
2,4552,8853,2912,6232,4521,280
Change in Working Capital
1,8181,795-615413-7941,409